These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38032864)

  • 1. Health care provider and client experiences of counselling on depot medroxyprogesterone acetate subcutaneous (DMPA-SC) for self-injection in Malawi.
    Porter Erlank C; Ali G; Birhanu F; Stanley M; Chirwa JS; Kachale F; Gunda A
    PLOS Glob Public Health; 2023; 3(11):e0002057. PubMed ID: 38032864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Client and provider experiences with self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Malawi.
    Burke HM; Packer C; Buluzi M; Healy E; Ngwira B
    Contraception; 2018 Nov; 98(5):405-410. PubMed ID: 29706227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Men can take part": examining men's role in supporting self-injectable contraception in southern Malawi, a qualitative exploration.
    Ruderman LW; Packer C; Zingani A; Moses P; Burke HM
    Reprod Health; 2022 Aug; 19(1):174. PubMed ID: 35945601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: a randomised controlled trial.
    Burke HM; Chen M; Buluzi M; Fuchs R; Wevill S; Venkatasubramanian L; Dal Santo L; Ngwira B
    Lancet Glob Health; 2018 May; 6(5):e568-e578. PubMed ID: 29526707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women's satisfaction, use, storage and disposal of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) during a randomized trial.
    Burke HM; Chen M; Buluzi M; Fuchs R; Wevill S; Venkatasubramanian L; Dal Santo L; Ngwira B
    Contraception; 2018 Nov; 98(5):418-422. PubMed ID: 29758176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Affecting Continued Use of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC): A Secondary Analysis of a 1-Year Randomized Trial in Malawi.
    Burke HM; Chen M; Buluzi M; Fuchs R; Wevill S; Venkatasubramanian L; Santo LD; Ngwira B
    Glob Health Sci Pract; 2019 Mar; 7(1):54-65. PubMed ID: 30894394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing a counseling message for increasing uptake of self-injectable contraception in southern Malawi: A mixed-methods, clustered randomized controlled study.
    Burke HM; Packer C; Zingani A; Moses P; Bernholc A; Ruderman LW; Martinez A; Chen M
    PLoS One; 2022; 17(10):e0275986. PubMed ID: 36256638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contraceptive self-injection through routine service delivery: Experiences of Ugandan women in the public health system.
    Cover J; Namagembe A; Morozoff C; Tumusiime J; Nsangi D; Drake JK
    Front Glob Womens Health; 2022; 3():911107. PubMed ID: 36060608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuation of self-injected versus provider-administered contraception in Senegal: a nonrandomized, prospective cohort study.
    Cover J; Ba M; Drake JK; NDiaye MD
    Contraception; 2019 Feb; 99(2):137-141. PubMed ID: 30439358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An observational study to test the acceptability and feasibility of using medical and nursing students to instruct clients in DMPA-SC self-injection at the community level in Kinshasa.
    Bertrand JT; Bidashimwa D; Makani PB; Hernandez JH; Akilimali P; Binanga A
    Contraception; 2018 Nov; 98(5):411-417. PubMed ID: 30120925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What Distinguishes Women Who Choose to Self-Inject? A Prospective Cohort Study of Subcutaneous Depot Medroxyprogesterone Acetate Users in Ghana.
    Nai D; Tobey E; Fuseini K; Kuma-Aboagye P; Jain A
    Glob Health Sci Pract; 2022 Feb; 10(1):. PubMed ID: 35294390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interest in self-administration of subcutaneous depot medroxyprogesterone acetate in the United States.
    Upadhyay UD; Zlidar VM; Foster DG
    Contraception; 2016 Oct; 94(4):303-13. PubMed ID: 27326938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives on DMPA-SC for self-injection among adolescents with unmet need for contraception in Malawi.
    Ali G; Porter Erlank C; Birhanu F; Stanley M; Chirwa J; Kachale F; Gunda A
    Front Glob Womens Health; 2023; 4():1059408. PubMed ID: 37034400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Provider acceptability of Sayana® Press: results from community health workers and clinic-based providers in Uganda and Senegal.
    Burke HM; Mueller MP; Packer C; Perry B; Bufumbo L; Mbengue D; Daff BM; Mbonye A
    Contraception; 2014 May; 89(5):368-73. PubMed ID: 24576792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of training in effective simulated self-injection of subcutaneous depot medroxyprogesterone acetate: observations from a usability study.
    Kaplan I; Ross D; Hilton F; Morgenstern D; Wolter K
    Contraception; 2016 Oct; 94(4):314-20. PubMed ID: 27241898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ugandan providers' views on the acceptability of contraceptive self-injection for adolescents: a qualitative study.
    Cover J; Namagembe A; Tumusiime J; Lim J; Cox CM
    Reprod Health; 2018 Oct; 15(1):165. PubMed ID: 30285779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introducing the subcutaneous depot medroxyprogesterone acetate injectable contraceptive via social marketing: lessons learned from Nigeria's private sector.
    Liu J; Schatzkin E; Omoluabi E; Fajemisin M; Onuoha C; Erinfolami T; Ayodeji K; Ogunmola S; Shen J; Diamond-Smith N; Sieverding M
    Contraception; 2018 Nov; 98(5):438-448. PubMed ID: 30071196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraceptive self-injection through routine service delivery: Health worker perspectives from Uganda.
    Morozoff C; Cover J; Namagembe A; Nsangi D; Komunyena Tumusiime J; Stout A; Kidwell Drake J
    Front Glob Womens Health; 2022; 3():890017. PubMed ID: 36204255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An implementation project to expand access to self-administered depot medroxyprogesterone acetate (DMPA).
    Katz M; Newmark RL; Aronstam A; O'Grady N; Strome S; Rafie S; Karlin J
    Contraception; 2020 Dec; 102(6):392-395. PubMed ID: 32931811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Task-shifting the provision of DMPA-SC in the DR Congo: Perspectives from two different groups of providers.
    Hernandez JH; Akilimali P; Glover A; Emel R; Mwembo A; Bertrand J
    Contraception; 2018 Nov; 98(5):449-453. PubMed ID: 30031000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.